BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22253820)

  • 1. Novel nonphosphorylated peptides with conserved sequences selectively bind to Grb7 SH2 domain with affinity comparable to its phosphorylated ligand.
    Zhang D; Shao C; Hu S; Ma S; Gao Y
    PLoS One; 2012; 7(1):e29902. PubMed ID: 22253820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel non-phosphorylated ligands, which bind selectively to the SH2 domain of Grb7.
    Pero SC; Oligino L; Daly RJ; Soden AL; Liu C; Roller PP; Li P; Krag DN
    J Biol Chem; 2002 Apr; 277(14):11918-26. PubMed ID: 11809769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Grb7 SH2 domain structure and interactions with a cyclic peptide inhibitor of cancer cell migration and proliferation.
    Porter CJ; Matthews JM; Mackay JP; Pursglove SE; Schmidberger JW; Leedman PJ; Pero SC; Krag DN; Wilce MC; Wilce JA
    BMC Struct Biol; 2007 Sep; 7():58. PubMed ID: 17894853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calorimetric investigation of phosphorylated and non-phosphorylated peptide ligand binding to the human Grb7-SH2 domain.
    Spuches AM; Argiros HJ; Lee KH; Haas LL; Pero SC; Krag DN; Roller PP; Wilcox DE; Lyons BA
    J Mol Recognit; 2007; 20(4):245-52. PubMed ID: 17705331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of the non-phosphorylated peptide G7-18NATE with Grb7-SH2 domain requires phosphate for enhanced affinity and specificity.
    Gunzburg MJ; Ambaye ND; Del Borgo MP; Pero SC; Krag DN; Wilce MC; Wilce JA
    J Mol Recognit; 2012 Jan; 25(1):57-67. PubMed ID: 22213451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis of binding by cyclic nonphosphorylated peptide antagonists of Grb7 implicated in breast cancer progression.
    Ambaye ND; Pero SC; Gunzburg MJ; Yap M; Clayton DJ; Del Borgo MP; Perlmutter P; Aguilar MI; Shukla GS; Peletskaya E; Cookson MM; Krag DN; Wilce MC; Wilce JA
    J Mol Biol; 2011 Sep; 412(3):397-411. PubMed ID: 21802427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis.
    Tanaka S; Pero SC; Taguchi K; Shimada M; Mori M; Krag DN; Arii S
    J Natl Cancer Inst; 2006 Apr; 98(7):491-8. PubMed ID: 16595785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grb7 binds to Hax-1 and undergoes an intramolecular domain association that offers a model for Grb7 regulation.
    Siamakpour-Reihani S; Peterson TA; Bradford AM; Argiros HJ; Haas LL; Lor SN; Haulsee ZM; Spuches AM; Johnson DL; Rohrschneider LR; Shuster CB; Lyons BA
    J Mol Recognit; 2011; 24(2):314-21. PubMed ID: 20665473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Grb7 is a downstream signaling component of platelet-derived growth factor alpha- and beta-receptors.
    Yokote K; Margolis B; Heldin CH; Claesson-Welsh L
    J Biol Chem; 1996 Nov; 271(48):30942-9. PubMed ID: 8940081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of crystals for characterizing the Grb7 SH2 domain before and after complex formation with a bicyclic peptide antagonist.
    Ambaye ND; Gunzburg MJ; Traore DA; Del Borgo MP; Perlmutter P; Wilce MC; Wilce JA
    Acta Crystallogr F Struct Biol Commun; 2014 Feb; 70(Pt 2):182-6. PubMed ID: 24637751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimerization in the Grb7 protein.
    Peterson TA; Benallie RL; Bradford AM; Pias SC; Yazzie J; Lor SN; Haulsee ZM; Park CK; Johnson DL; Rohrschneider LR; Spuches A; Lyons BA
    J Mol Recognit; 2012 Aug; 25(8):427-34. PubMed ID: 22811067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and crystallization of the Grb7 SH2 domain in complex with the G7-18NATE nonphosphorylated cyclic inhibitor peptide.
    Yap MY; Wilce MC; Clayton DJ; Perlmutter P; Aguilar MI; Wilce JA
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Dec; 66(Pt 12):1640-3. PubMed ID: 21139214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The intertwining of structure and function: proposed helix-swapping of the SH2 domain of Grb7, a regulatory protein implicated in cancer progression and inflammation.
    Pias S; Peterson TA; Johnson DL; Lyons BA
    Crit Rev Immunol; 2010; 30(3):299-304. PubMed ID: 20370637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic Peptides Incorporating Phosphotyrosine Mimetics as Potent and Specific Inhibitors of the Grb7 Breast Cancer Target.
    Watson GM; Gunzburg MJ; Ambaye ND; Lucas WA; Traore DA; Kulkarni K; Cergol KM; Payne RJ; Panjikar S; Pero SC; Perlmutter P; Wilce MC; Wilce JA
    J Med Chem; 2015 Oct; 58(19):7707-18. PubMed ID: 26359549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for dimerization of the Grb10 Src homology 2 domain. Implications for ligand specificity.
    Stein EG; Ghirlando R; Hubbard SR
    J Biol Chem; 2003 Apr; 278(15):13257-64. PubMed ID: 12551896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Cyclic Peptide Inhibitors of the Grb7 Breast Cancer Target: Small Change in Cargo Results in Large Change in Cellular Activity.
    Sang J; Kulkarni K; Watson GM; Ma X; Craik DJ; Henriques ST; Poth AG; Benfield AH; Wilce JA
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31627265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery, Development, and Cellular Delivery of Potent and Selective Bicyclic Peptide Inhibitors of Grb7 Cancer Target.
    Watson GM; Kulkarni K; Sang J; Ma X; Gunzburg MJ; Perlmutter P; Wilce MCJ; Wilce JA
    J Med Chem; 2017 Nov; 60(22):9349-9359. PubMed ID: 29083893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Backbone nuclear relaxation characteristics and calorimetric investigation of the human Grb7-SH2/erbB2 peptide complex.
    Ivancic M; Spuches AM; Guth EC; Daugherty MA; Wilcox DE; Lyons BA
    Protein Sci; 2005 Jun; 14(6):1556-69. PubMed ID: 15930003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural determinants of the interaction between the erbB2 receptor and the Src homology 2 domain of Grb7.
    Janes PW; Lackmann M; Church WB; Sanderson GM; Sutherland RL; Daly RJ
    J Biol Chem; 1997 Mar; 272(13):8490-7. PubMed ID: 9079677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uptake of a cell permeable G7-18NATE contruct into cells and binding with the Grb-7-SH2 domain.
    Ambaye ND; Lim RC; Clayton DJ; Gunzburg MJ; Price JT; Pero SC; Krag DN; Wilce MC; Aguilar MI; Perlmutter P; Wilce JA
    Biopolymers; 2011; 96(2):181-8. PubMed ID: 20564009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.